Suppr超能文献

[丙酸倍氯米松、布地奈德和氟尼缩松治疗支气管哮喘(文献综述及作者自身研究)]

[Beclomethasone dipropionate, budesonide and flunisolide in the treatment of bronchial asthma (a review of the literature and the authors' own research)].

作者信息

Kakhnovskiĭ I M, Solomatin A S

出版信息

Ter Arkh. 1995;67(3):34-8.

PMID:7770801
Abstract

Inhalation corticosteroids (beclometasone dipropionate, budesonide, flunisolide) proved effective against bronchial asthma (BA) and safe as they induce no severe systemic side effects. Of these three drugs side effects arise most frequently in administration of beclometasone dipropionate, least frequently of flunisolide. These inhalation corticosteroids are indicated both in non-steroid-dependent and steroid-dependent BA to reduce the dose of oral steroids or, if possible, for their complete discontinuation. Flunisolide is the most potent and effective of all inhalation corticosteroids used in current practice.

摘要

吸入性皮质类固醇(二丙酸倍氯米松、布地奈德、氟尼缩松)已被证明对支气管哮喘(BA)有效且安全,因为它们不会引起严重的全身副作用。在这三种药物中,二丙酸倍氯米松给药时出现副作用的频率最高,氟尼缩松出现的频率最低。这些吸入性皮质类固醇适用于非类固醇依赖型和类固醇依赖型BA,以减少口服类固醇的剂量,或者在可能的情况下,完全停用口服类固醇。氟尼缩松是目前临床使用的所有吸入性皮质类固醇中效力最强、效果最好的。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验